Zhenying Zhao

ORCID: 0000-0003-1307-6023
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Head and Neck Cancer Studies
  • Metabolism, Diabetes, and Cancer
  • Diabetes Treatment and Management
  • Cancer Treatment and Pharmacology
  • Lung Cancer Treatments and Mutations
  • Oral health in cancer treatment
  • Peroxisome Proliferator-Activated Receptors
  • Cancer-related gene regulation
  • Dermatology and Skin Diseases
  • Plant and Fungal Species Descriptions
  • Colorectal Cancer Screening and Detection
  • Cancer Genomics and Diagnostics
  • Respiratory and Cough-Related Research
  • Vasculitis and related conditions
  • Myasthenia Gravis and Thymoma
  • Genomic variations and chromosomal abnormalities
  • Nonmelanoma Skin Cancer Studies
  • Treatment of Major Depression
  • Asthma and respiratory diseases
  • Gut microbiota and health
  • Phytoestrogen effects and research
  • Adipokines, Inflammation, and Metabolic Diseases
  • Alzheimer's disease research and treatments
  • Botany and Plant Ecology Studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies

Nankai University
2013-2024

Tianjin People's Hospital
2021-2023

First Affiliated Hospital of Guangzhou University of Chinese Medicine
2021

Second Military Medical University
2011

Changhai Hospital
2011

Chinese People's Liberation Army
2011

Takeda (United States)
2009

Chinese Academy of Sciences
1984

Background. Over the past decades, lots of advance have occurred in prevention, diagnosis, and treatment head neck cancer (HNC). However, contemporaneous incidence survival trends, on basis population-based registry, not been reported. Methods. The HNC cases were accessed from Surveillance, Epidemiology, End Results (SEER) database. trend was analyzed by joinpoint analysis, with being period analysis relative rate (RSR) Kaplan-Meier analyses. Cox regression performed to identify prognostic...

10.1155/2021/1738932 article EN cc-by BioMed Research International 2021-07-14

Abstract Background Qingfei Xiaoyan Wan (QFXY), a traditional Chinese formula, is widely used for relieving cough, asthma, upper respiratory tract infection, bronchitis, pneumonia, and etc. in clinic. Comparing with other anti-asthma drugs, it characterised moderate persistent efficacy as well few side effects, however, the underlying action mechanism still remains elusive. This study aimed to identify QFXY multi-target network regulation an asthma controller. Methods established model...

10.1186/1472-6882-13-206 article EN cc-by BMC Complementary and Alternative Medicine 2013-08-06

<p>Colorectal cancer (CRC) continuously ranks as the third most common cause of cancer-related deaths worldwide. Based on anatomical classifications and clinical diagnoses, CRC is classified into right-sided, left-sided, rectal CRC. Importantly, three types positional-specific affect prognosis outcomes, thus indicating that treatments for are required. Emerging evidence suggests besides host genetic epigenetic alterations, gut mucosal microbiota linked to inflammation, occurrence,...

10.3934/microbiol.2024035 article EN cc-by AIMS Microbiology 2024-01-01
Coming Soon ...